Pentamaks Trademark Details

Pentamaks was registered on Tuesday, May 27, 2003 and is currently owned by Glaxo Group Limited under the registration number 2718432 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 10 years ago on Friday, January 3, 2014, according to the United State Patent & Trademark Office
Word Mark Pentamaks
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Glaxo Group Limited

View all trademarks for Glaxo Group Limited

Previous Owners

Sanofi-Synthelabo of Paris, TX

View all trademarks for Sanofi-Synthelabo
Other Trademarks for Sanofi-Synthelabo

N. V. Organon

View all trademarks for N. V. Organon
Serial Number 76090956
Registration Number 2718432
Status Date Friday, January 3, 2014
Filing Date Friday, January 3, 2014
Registration Date Tuesday, May 27, 2003
Attorney Diane Fry Maginnis
Domestic Representative Diane Fry Maginnis

Correspondent

Diane Fry Maginnis
GlaxoSmithKline
LGTM, C.3157.3D
Five Moore Drive
Research Triangle Park NC 27709

Case File Statements

Goods & Services Conduct of Clinical Trials in the Area of Medical Science

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, January 3, 2014
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.